These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28698456)

  • 1. Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin.
    Mauri L; Marinozzi M; Mazzini G; Kolinski RE; Karfunkle M; Keire DA; Guerrini M
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
    Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
    Volpi N
    Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach.
    Gardini C; Urso E; Guerrini M; van Herpen R; de Wit P; Naggi A
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28678201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
    Volpi N
    Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-pressure, anion-exchange chromatography of proteoglycans.
    Blake DA; McLean NV
    Anal Biochem; 1990 Nov; 190(2):158-64. PubMed ID: 2291462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
    Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structural characterization of sulodexide.
    Veraldi N; Guerrini M; Urso E; Risi G; Bertini S; Bensi D; Bisio A
    J Pharm Biomed Anal; 2018 Jul; 156():67-79. PubMed ID: 29689470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion chromatography for the separation of heparin and structurally related glycoaminoglycans: A review.
    Fasciano JM; Danielson ND
    J Sep Sci; 2016 Mar; 39(6):1118-29. PubMed ID: 26800335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches.
    Keire DA; Mans DJ; Ye H; Kolinski RE; Buhse LF
    J Pharm Biomed Anal; 2010 Sep; 52(5):656-64. PubMed ID: 20233649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools for the Quality Control of Pharmaceutical Heparin.
    Devlin A; Mycroft-West C; Procter P; Cooper L; Guimond S; Lima M; Yates E; Skidmore M
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31557911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
    Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
    J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate.
    Sudo M; Sato K; Chaidedgumjorn A; Toyoda H; Toida T; Imanari T
    Anal Biochem; 2001 Oct; 297(1):42-51. PubMed ID: 11567526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of currently marketed heparin products: key tests for quality assurance.
    Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
    Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
    Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
    Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
    Hu P; Fang L; Chess EK
    Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.